A Cross-Sectional Study of Alzheimer-Related Proteins in Women with Polycystic Ovary Syndrome
-
Published:2024-01-18
Issue:2
Volume:25
Page:1158
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Butler Alexandra E.1ORCID, Moin Abu Saleh Md1, Sathyapalan Thozhukat2ORCID, Atkin Stephen L.1ORCID
Affiliation:
1. Research Department, Royal College of Surgeons of Ireland, Busaiteen P.O. Box 15503, Bahrain 2. Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU6 7RU, UK
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine condition in women of reproductive age, and several risk factors found in PCOS are associated with an increased risk of Alzheimer’s disease (AD). Proteins increased in AD have been reported to include fibronectin (FN) fragments 3 and 4 (FN1.3 and FN1.4, respectively) and ApoE. We hypothesized that Alzheimer-related proteins would be dysregulated in PCOS because of associated insulin resistance and obesity. In this comparative cross-sectional analysis, aptamer-based SomaScan proteomic analysis for the detection of plasma Alzheimer-related proteins was undertaken in a PCOS biobank of 143 women with PCOS and 97 control women. Amyloid precursor protein (APP) (p < 0.05) and amyloid P-component (APCS) (p < 0.001) were elevated in PCOS, while alpha-synuclein (SNCA) (p < 0.05) was reduced in PCOS. Associations with protective heat shock proteins (HSPs) showed that SNCA positively correlated with HSP90 (p < 0.0001) and HSP60 (p < 0.0001) in both the PCOS and control women. Correlations with markers of inflammation showed that APCS correlated with interleukin 6 (IL6) (p = 0.04), while Apolipoprotein (Apo) E3 correlated with TNF-alpha (p = 0.02). FN, FN1.3, FN1.4 and ApoE were all elevated significantly (p < 0.05). An AD-associated protein pattern with elevated FN, FN1.3, FN1.4 and ApoE was found in PCOS, in addition to elevated APP and reduced SNCA, which was the same as reported for type 2 diabetes (T2D) with, additionally, an elevation in APCS. With the AD biomarker pattern in PCOS being very similar to that in T2D, where there is an association between AD and T2D, this suggests that larger prospective cohort studies are needed in women with PCOS to determine if there is a causal association with AD.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference75 articles.
1. Recent advances in cardiovascular aspects of polycystic ovary syndrome;Sathyapalan;Eur. J. Endocrinol./Eur. Fed. Endocr. Soc.,2012 2. Astaxanthin treatment ameliorates ER stress in polycystic ovary syndrome patients: A randomized clinical trial;Jabarpour;Sci. Rep.,2023 3. Butler, A.E., Moin, A.S.M., Reiner, Ž., Sathyapalan, T., Jamialahmadi, T., Sahebkar, A., and Atkin, S.L. (2023). HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study. Cells, 12. 4. Armanini, D., Boscaro, M., Bordin, L., and Sabbadin, C. (2022). Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism. Int. J. Mol. Sci., 23. 5. Al-Mutawa, J. (2023). Genetic contribution between APE1 variants in polycystic ovarian syndrome. Saudi J. Biol. Sci., 30.
|
|